The leading digital health startup in the Baltics, Longenesis, in collaboration with Daugavpils Regional Hospital (DRH) and the international pharmaceutical company Novartis Baltics, has signed a Memorandum of Understanding to launch a pilot project in Latvia for the treatment and prevention of cardiovascular diseases. The project aims to create a dynamic digital registry for heart failure and dyslipidemia patients, enhancing risk group identification and enabling timely treatment. Patient enrolment is set to begin at Daugavpils Regional Hospital in early 2025.
The registry will securely collect data from multiple information systems into a regularly updated patient overview panel for doctors. This dynamic patient monitoring option will enable doctors to track changes in the patient's condition, reflecting their current risk factors, thus improving the quality and timeliness of treatment. Dr. Deniss Vasiljevs, cardiologist at DRH Cardiology and Internal Medicine Center and DRH Director of Science and Education emphasises: "The dynamic patient registry will be more than just a technological solution, but a model for modern cardiovascular disease treatment", which will help reduce the number of hospitalisations and improve patient outcomes.
At the opening event of the pilot project, the opinion of patients was represented by Inese Maurina, Head of the Cardiology Patient Association ParSirdi.lv, who attested to the relevance of the project and the use of digital technologies to improve patient treatment. Cardiovascular diseases are still the most common cause of death in Latvia, claiming 14,395 lives in 2023, with Latgale standing out with the proportionally highest mortality rates. Edgars Labsvirs, Member of the Board of the Daugavpils Regional Hospital, states: "Modern treatment is not limited to the discharge of the patient from the hospital; it should be dynamic and adapt to each patient. We are proud to be part of a pilot project that is being implemented in Latgale."
An essential component of the pilot project is interdisciplinary cooperation, combining knowledge, skills, and resources to systematically solve complex healthcare challenges. Liene Silina, Member of the Board of Novartis Baltics, confirms the company’s goal to improve and extend patients’ lives: “Modern treatment must adapt to technological advances and changing patient needs in order to increase treatment effectiveness.”
Emil Syundyukov, Co-Founder and CEO of Longenesis points out that the dynamic patient registry is just the beginning of broader changes in the healthcare system: “Countries all over the world are facing challenges in the field of cardiovascular diseases, so our goal is to use the success of this project as a stepping stone to scale such solutions in the Baltics and Europe.”
At the opening event of the pilot project, it was emphasised that a dynamic patient registry solution not only highlights the importance of innovation and digitisation in healthcare, but also proves that such innovations are possible in all regions of Latvia. Longenesis, Daugavpils Regional Hospital, and Novartis Baltics are joining forces to create more effective solutions in the prevention and treatment of cardiovascular diseases, significantly improving the overall quality of healthcare in Latvia.
The registry will securely collect data from multiple information systems into a regularly updated patient overview panel for doctors. This dynamic patient monitoring option will enable doctors to track changes in the patient's condition, reflecting their current risk factors, thus improving the quality and timeliness of treatment. Dr. Deniss Vasiljevs, cardiologist at DRH Cardiology and Internal Medicine Center and DRH Director of Science and Education emphasises: "The dynamic patient registry will be more than just a technological solution, but a model for modern cardiovascular disease treatment", which will help reduce the number of hospitalisations and improve patient outcomes.
At the opening event of the pilot project, the opinion of patients was represented by Inese Maurina, Head of the Cardiology Patient Association ParSirdi.lv, who attested to the relevance of the project and the use of digital technologies to improve patient treatment. Cardiovascular diseases are still the most common cause of death in Latvia, claiming 14,395 lives in 2023, with Latgale standing out with the proportionally highest mortality rates. Edgars Labsvirs, Member of the Board of the Daugavpils Regional Hospital, states: "Modern treatment is not limited to the discharge of the patient from the hospital; it should be dynamic and adapt to each patient. We are proud to be part of a pilot project that is being implemented in Latgale."
An essential component of the pilot project is interdisciplinary cooperation, combining knowledge, skills, and resources to systematically solve complex healthcare challenges. Liene Silina, Member of the Board of Novartis Baltics, confirms the company’s goal to improve and extend patients’ lives: “Modern treatment must adapt to technological advances and changing patient needs in order to increase treatment effectiveness.”
Emil Syundyukov, Co-Founder and CEO of Longenesis points out that the dynamic patient registry is just the beginning of broader changes in the healthcare system: “Countries all over the world are facing challenges in the field of cardiovascular diseases, so our goal is to use the success of this project as a stepping stone to scale such solutions in the Baltics and Europe.”
At the opening event of the pilot project, it was emphasised that a dynamic patient registry solution not only highlights the importance of innovation and digitisation in healthcare, but also proves that such innovations are possible in all regions of Latvia. Longenesis, Daugavpils Regional Hospital, and Novartis Baltics are joining forces to create more effective solutions in the prevention and treatment of cardiovascular diseases, significantly improving the overall quality of healthcare in Latvia.